Monocyte Chemoattractant Protein-1 (MCP-1) is a small cytokine that plays a key role in the recruitment and activation of monocytes and macrophages to sites of inflammation.
It is involved in a variety of inflammatory and immune responses, and has been implicated in the pathogenesis of numerous disease states.
MCP-1 is produced by a wide range of cell types, including endothelial cells, smooth muscle cells, and various immune cells.
It exrts its effects by binding to the CCR2 receptor, which triggers intracellular signaling cascades that promote monocyte migration and activation.
Accurate measurement and analysis of MCP-1 levels is crucial for understanding its role in health and disease, and optimizing your research in this area can be greatly facilitated by the use of PubCompare.ai's AI-driven platform.
Most cited protocols related to «Monocyte Chemoattractant Protein-1»
Blood and/or urine was collected from burn patients at admission, pre-operatively, and 5 days post-operatively for 4 weeks for serum hormone, protein, cytokine and urine hormone analysis. Blood was drawn in a serum-separator collection tube and centrifuged for 10 minutes at 1320 rpm; the serum was removed and stored at −70°C until assayed. Serum hormones and acute phase proteins were determined using HPLC, nephelometry (BNII, Plasma Protein Analyzer Dade Behring, MD), and ELISA techniques. The Bio-Plex Human Cytokine 17-Plex panel was used with the Bio-Plex Suspension Array System (Bio-Rad, Hercules, CA) to profile expression of seventeen inflammatory mediators interleukin [IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12p70, IL-13, IL-17, granulocyte colony stimulating factor (GCSF), granulocyte macrophage colony stimulating factor (GMCSF), interferon-gamma (IFN-γ), monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1 beta (MIP-1β), and tumor necrosis factor (TNF). The assay was performed according to the manufacturer’s instructions. Briefly, serum samples were thawed and then centrifuged at 4500 rpm for 3 minutes at 4°C. Serum samples were then incubated with microbeads labeled with specific antibodies to one of the aforementioned cytokines for 30 minutes. Following a wash step, the beads were incubated with the detection antibody cocktail, each antibody specific to a single cytokine. After another wash step, the beads were incubated with streptavidin-phycoerythrin for 10 minutes, washed, and the concentrations of each cytokine were determined using the array reader.3 (link), 18 (link)–20 (link)Urine creatinine, creatinine clearance, and cortisol were determined by standard laboratory techniques.
Jeschke M.G., Chinkes D.L., Finnerty C.C., Kulp G., Suman O.E., Norbury W.B., Branski L.K., Gauglitz G.G., Mlcak R.P, & Herndon D.N. (2008). THE PATHOPHYSIOLOGIC RESPONSE TO SEVERE BURN INJURY. Annals of surgery, 248(3), 387-401.
DNA and gene expression analysis were performed on 54 tumor specimens from Leiden, in which the BAP1 status was known. The QIAmp DNA Mini kit was used to isolate DNA for single-nucleotide polymorphism (SNP) analysis (Qiagen, Venlo, The Netherlands). SNP analysis was then performed with the Affymetrix 250K_NSP microarray and Affymetrix Cytoscan HD chip (Affymetrix, Santa Clara, California, United States of America) to detect aberrations of chromosome 3 as described previously [20 (link)]. Information on chromosome 8q was obtained by digital polymerase chain reaction (dPCR) [20 (link)]. A threshold of >2.1 was defined as having extra copies of chromosome 8q. The RNeasy mini kit was used to isolate RNA for gene expression analyses (Qiagen, Venlo, The Netherlands). Gene expression levels of CD3 and CD8 (T cells), CD68 (macrophages), and pro-inflammatory cytokines, specifically macrophage inflammatory protein 1α (CCL3), vascular endothelial growth factor A (VEGFA), stromal cell-derived factor 1 (CXCL12), CCL7, CSF-1, monocyte chemoattractant protein-1 (CCL2), RANTES (CCL5), interferon gamma-induced protein 10 (CXCL10), CCR7, and CXCR4 were obtained using the Illumina HT-12 v4 chip (Illumina, San Diego, California, United States of America). The pro-inflammatory cytokines were selected based on our previous papers [31 (link)–33 (link)]. We could validate the probes for CD3,CD8 and CD68 in 24 tumors in which gene expression levels had been determined with an Illumina HT12 v4 array and in which the number of infiltrating cells was analyzed by IF. In addition, data on RNA sequencing and Affymetrix SNP 6.0 array from 80 samples of UM were obtained from the TCGA Research Network: http://cancergenome.nih.gov/. Copy numbers for 8q were determined by Affymetrix SNP 6.0 array and analyzed with the GISTIC 2.0 algorithm [34 (link), 35 (link)]. Copy numbers >2 were categorized as extra copies of chromosome 8q. BAP1, CD68, CD3, and CD8 expression were obtained by RNA sequencing and quantified as log2(RSEM+1). BAP1 expression was dichotomized into BAP1-positive and BAP1-negative expression at the median.
Gezgin G., Dogrusöz M., van Essen T.H., Kroes W.G., Luyten G.P., van der Velden P.A., Walter V., Verdijk R.M., van Hall T., van der Burg S.H, & Jager M.J. (2017). Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment. Cancer Immunology, Immunotherapy, 66(7), 903-912.
Serum interleukin-9 (IL-9), interleukin-1β (IL-1β), macrophage inflammatory protein-1α (MIP-1α), angiogenin, granulocyte colony-stimulating factor (G-CSF), interleukin-1α (IL-1α), monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein-1β (MIP-1β), immunoglobulin E (IgE), interleukin-6 (IL-6), fractalkine, interleukin-8 (IL-8), tumor necrosis factor-α (TNF-α), monokine induced by interferon-gamma (MIG), rantes, and granzyme B were analyzed by multiparameter flow cytometry using the corresponding antibodies from BD Biosciences (East Rutherford, NJ, United States) and the BD FACSymphony™A5 (BD Biosciences).
Cai S., Lin J., Li Z., Liu S., Feng Z., Zhang Y., Zhang Y., Huang J, & Chen Q. (2023). Alterations in intestinal microbiota and metabolites in individuals with Down syndrome and their correlation with inflammation and behavior disorders in mice. Frontiers in Microbiology, 14, 1016872.
angiogenin Antibodies CCL3 protein, human CCL4 protein, human CCL5 protein, human Flow Cytometry Fractalkine Granulocyte Colony-Stimulating Factor GZMB protein, human IL1A protein, human IL1B protein, human Immunoglobulin E Interferon Type II Interleukin-1 beta Interleukin-9 Monocyte Chemoattractant Protein-1 Monokines Serum Tumor Necrosis Factor-alpha
Mice at the fed state or fasted for 12 h were sacrificed, and whole blood was collected from retrobulbar venous plexus and centrifuged for 10 min at 12,000 × g to obtain plasma. Plasma glucose, total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), very low-density lipoprotein (VLDL), and total triglycerides were measured using commercial kits (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). ELISA kits (Sinoukbio, Beijing, China) were used to measure plasma insulin, C-peptide, non-esterified fatty acid (NEFA), leptin, IL (interleukin) 4, IL6, IL10, resistin, interferon γ (IFNγ) and monocyte chemotactic protein-1 (MCP1) following the manufacturer’s instruction.
Zhang X., Wang L., Wang Y., He L., Xu D., Yan E., Guo J., Ma C., Zhang P, & Yin J. (2023). Lack of adipocyte IP3R1 reduces diet-induced obesity and greatly improves whole-body glucose homeostasis. Cell Death Discovery, 9, 87.
BLOOD C-Peptide Cholesterol Enzyme-Linked Immunosorbent Assay Fatty Acids, Esterified Glucose High Density Lipoproteins IL10 protein, human Insulin Interferon Type II Interleukin-4 Leptin Low-Density Lipoproteins Monocyte Chemoattractant Protein-1 Mus Plasma RETN protein, human Triglycerides Veins Very Low Density Lipoprotein
Itching assessment. The intensity of pruritus was assessed using a numerical rating scale (NRS; 0 = ”no pruritus,” 1–2 = ”mild pruritus,” 3–6 = ”moderate pruritus,” 7–8 = ”severe pruritus”, 9–10 = ”very severe pruritus”) (11 (link)) and the 12-item Pruritus Severity Score (12–PSS, 3–6 points = ”mild pruritus,” 7–11 points = ”moderate pruritus,” and 12–22 points = ”severe pruritus”) (12 (link)). The NRS score reflects mean pruritus within the past 24 h. The treatment modalities for itching, including systemic and topical drugs, were also documented. Multiplex immunoassay. The mediator levels in 87 sera samples were analysed by the Inflammation Core Facility, Institute of Biomedical Sciences, Academia Sinica, Taiwan. The core facility is funded by the Academia Sinica Core Facility and Innovative Instrument Project (AS-CFII-108-118; support number: 206f-1083818). Blood samples were collected using an antiblocked reagent and then diluted 4- and 7-fold for the quantification of mediator levels. The levels of 21 mediators were measured in duplicate, and these mediators are outlined as follows: interleukin (IL)-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-9, IL-12, IL-13, IL-15, IL-17A, IL-23, tumour necrosis factor (TNF)-α, interferon-γ (IFN-γ), IL-31, granulocyte colony-stimulating factor (G-CSF), granulocyte–macrophage colony-stimulating factor (GM-CSF), C-X-C motif chemokine ligand 10 (CXCL10), monocyte chemoattractant protein-1 (MCP-1), high-sensitivity C-reactive protein, and transforming growth factor beta (TGF-β). In brief, antibody-coupled magnetic beads were incubated with standard or sera samples for 2 h. After being washed, the beads were incubated with detection antibody for 1 h, washed, and subsequently incubated with 1 μg/mL streptavidin–phycoerythrin (SA–PE) for 30 min. The beads were rewashed, suspended in 100 μL assay buffer, and analysed through a Bio-Plex 200 system (Bio-Rad, Hercules, CA, USA). All assays were protected from light and performed at room temperature. The detection limits of the 21 mediators are listed in Table SI. Biochemistry. Venous blood samples were collected to measure fasting plasma glucose (fasting period of at least 8 h), postprandial (2 h after a meal) plasma glucose, glycated haemoglobin A1c (HbA1c), creatinine, estimated glomerular filtration rate (eGFR), and alanine aminotransferase (ALT) levels by using central laboratory systems.
He G.Y., Hsu T.Y., Chen C.W., Nien F.J., Chen H.Y., Chu C.Y, & Wang L.F. (2023). Serum Mediators in Patients with Both Type 2 Diabetes Mellitus and Pruritus. Acta Dermato-Venereologica, 103, 4863.
IL-6, IL-8, monocyte chemoattractant protein (MCP)-1, GDF-15 were determined in senescent fibroblast supernatant, and WNT16 levels were determined in senescent fibroblast lysates using a standardized sandwich ELISA technique (R&D Systems, Minneapolis, MN, USA), according to manufacturer’s protocol. Results were expressed as fold-change compared to control cells.
Badaro-Garcia S., Hohmann M.S., Coelho A.L., Verri WA J.r, & Hogaboam C.M. (2023). Standard of care drugs do not modulate activity of senescent primary human lung fibroblasts. Scientific Reports, 13, 3654.
Serum concentrations of the following biomarkers will be measured. Rheumatoid factor (RF) will be measured using latex agglutination turbidimetric immunoassay (LZ test “Eiken” RF). Anti-cyclic citrullinated peptide antibodies will be measured using a chemiluminescent immunoassay (STACIA MEBLux test CCP). Matrix metalloproteinase-3 (MMP-3) was measured using a latex turbidimetric immunoassay (Panaclear MMP-3 “Latex”). Multiplex cytokine/chemokine bead assays will be performed using diluted serum supernatants and MILLIPLEX MAP Human Cytokine/Chemokine Magnetic Bead Panel (Merck Millipore)–Bio-Plex Pro Human Cytokine Assays (Bio-Rad) analyzed with a Bio-Plex MAGPIX Multiplex Reader (Bio-Rad), according to the manufacturer’s instructions. The cytokines/chemokines that are measured by the bead panel include interleukin (IL)-1α, IL-1β, IL-1 receptor antagonist, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-17A, IL-17F, IL-18, IL-22, IL-27, interferon-gamma (IFN-γ), IFN-α2, CXCL1 (growth-related oncogene), granulocyte–macrophage colony-stimulating factor, granulocyte colony-stimulating factor, CX3CL1 (fractalkine), flt-3 ligand, fibroblast growth factor-2, eotaxin, epidermal growth factor, vascular endothelial growth factor, platelet-derived growth factor-AA, soluble CD40 ligand, TNF-α, TNF-β, transforming growth factor-α, CCL4 (macrophage inflammatory protein [MIP]-1β), CCL3 (MIP-1α), CCL22 (macrophage-derived chemokine), CCL7 (monocyte chemotactic protein-3), CCL2 (monocyte chemotactic protein-1), CXCL10 (IFN-γ-inducible protein-10), vascular cell adhesion molecule-1, and intercellular adhesion molecule-1. The serum IL-6 and TNF-α levels will be measured using specific enzyme-linked immunosorbent assay kits (R&D Systems). Residual serum samples will be stored at Nagasaki University Hospital for 5 years after the completion of the study for future research.
Shimizu T., Kawashiri S.Y., Morimoto S., Kawazoe Y., Kuroda S., Kawasaki R., Ito Y., Kiya R., Sato S., Yamamoto H, & Kawakami A. (2023). Efficacy and safety of selective JAK 1 inhibitor filgotinib in active rheumatoid arthritis patients with inadequate response to methotrexate: comparative study with filgotinib and tocilizumab examined by clinical index as well as musculoskeletal ultrasound assessment (TRANSFORM study): study protocol for a randomized, open-label, parallel-group, multicenter, and non-inferiority clinical trial. Trials, 24, 161.
Sourced in United States, United Kingdom, Germany, Canada, France, Belgium, Switzerland, China, Austria, Sweden, Australia, Japan, Italy
The Bio-Plex 200 system is a multiplex immunoassay platform that allows for the simultaneous detection and quantification of multiple analytes in a single sample. The system utilizes fluorescently-labeled magnetic beads and a dual-laser detection system to perform high-throughput, multiplexed analyses.
Sourced in United States, China, Japan, Germany, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Netherlands, Belgium, Lithuania, Denmark, Singapore, New Zealand, India, Brazil, Argentina, Sweden, Norway, Austria, Poland, Finland, Israel, Hong Kong, Cameroon, Sao Tome and Principe, Macao, Taiwan, Province of China, Thailand
TRIzol reagent is a monophasic solution of phenol, guanidine isothiocyanate, and other proprietary components designed for the isolation of total RNA, DNA, and proteins from a variety of biological samples. The reagent maintains the integrity of the RNA while disrupting cells and dissolving cell components.
Sourced in United States, Canada, France, Germany, United Kingdom, Belgium, Japan, Sweden, Australia
The Bio-Plex 200 is a multiplex detection system that utilizes magnetic beads and dual-laser fluorescence detection to quantify multiple analytes in a single sample. The system is designed to enable simultaneous measurement of up to 100 different biomolecules in a small sample volume.
Sourced in Germany, United States, United Kingdom, Netherlands, Spain, Japan, Canada, France, China, Australia, Italy, Switzerland, Sweden, Belgium, Denmark, India, Jamaica, Singapore, Poland, Lithuania, Brazil, New Zealand, Austria, Hong Kong, Portugal, Romania, Cameroon, Norway
The RNeasy Mini Kit is a laboratory equipment designed for the purification of total RNA from a variety of sample types, including animal cells, tissues, and other biological materials. The kit utilizes a silica-based membrane technology to selectively bind and isolate RNA molecules, allowing for efficient extraction and recovery of high-quality RNA.
Sourced in United States, Germany, United Kingdom, Belgium, Japan, France, China, Australia, Italy, Spain, Canada, Switzerland, Sweden, Brazil, India, Mexico, Austria
The FACSCanto II is a flow cytometer manufactured by BD. It is a versatile instrument designed for multicolor flow cytometric analysis. The FACSCanto II can detect and analyze various properties of cells or particles suspended in a fluid as they flow through the system.
Sourced in United States, Germany, United Kingdom, Canada, Sweden, Italy
Bio-Plex Manager software is a data analysis tool designed for use with Bio-Rad's Bio-Plex multiplex assay system. It provides functionality for data acquisition, analysis, and visualization.
Sourced in United States, Germany, Canada, France, Morocco, Australia, United Kingdom
The Milliplex MAP Kit is a multiplex assay platform developed by Merck Group. The kit enables the simultaneous detection and measurement of multiple analytes in a single sample. The core function of the Milliplex MAP Kit is to provide a versatile and efficient tool for researchers to conduct multiplexed biomarker analysis.
MCP-1 is a protein that plays a role in the immune system by attracting and activating certain types of immune cells. It is involved in the recruitment of monocytes, memory T cells, and natural killer cells to sites of inflammation or infection.
The CBA Mouse Inflammation Kit is a laboratory tool designed to measure the levels of specific inflammatory cytokines in mouse samples. It provides a multi-analyte quantitative assessment of these cytokines using flow cytometry technology.
Monocyte Chemoattractant Protein-1 (MCP-1) is a specific chemokine that exists in multiple isoforms. The most common forms are MCP-1/CCL2, which is the primary and best-studied variant, as well as the less abundant MCP-1/CCL2 splice variants. These different isoforms may exhibit slightly varied biological activities and functions, so it's important to be aware of which specific form you are working with in your research.
MCP-1 plays a crucial role in a variety of inflammatory and immune-related processes, making it a valuable biomarker and therapeutic target in many disease states. Some of the key applications of MCP-1 include:
- Monitoring and assessing the progression of inflammatory diseases like atherosclerosis, rheumatoid arthritis, and diabetic nephropathy
- Evaluating the efficacy of anti-inflammatory treatments by measuring changes in MCP-1 levels
- Investigating the role of MCP-1 in the pathogenesis of neurological disorders like multiple sclerosis and Alzheimer's disease
- Exploring the potential of MCP-1-targeted therapies for conditions characterized by excessive monocyte/macrophage infiltration and activation.
Accurately quantifying MCP-1 levels can be challenging due to several factors, including:
- Variability in sample collection and processing methods
- Differences in assay sensitivity and specificity across available detection kits
- The presence of MCP-1 isoforms with slightly different structures and functions
- Potential interference from other molecules in complex biological samples
To address these challenges, it is important to use well-validated and standardized protocols, as well as to compare results across multiple assay platforms. The PubCompare.ai platform can be particularly helpful in this regard, as it allows researchers to identify the most robust and effective methods for MCP-1 quantification based on a comprehensive analysis of the scientific literature.
PubCompare.ai's AI-driven platform can greatly facilitate your Monocyte Chemoattractant Protein-1 (MCP-1) research in several ways:
1. Efficinet protocol screening: PubCompare.ai allows you to rapidly screen the scientific literature to identify the most effective and reproducible protocols for MCP-1 measurement and analysis.
2. AI-driven insights: The platform's AI algorithms can pinpoint critical insights, such as key differences in the performance of various MCP-1 detection methods or the most suitable sample types and pretreatment procedures.
3. Optimized research: By leveraging PubCompare.ai's powerful tools, you can choose the best protocols and products for your specific MCP-1 research goals, leading to more accurate and reproducible results.
Don't miss out on this invaluable resource for your Monocyte Chemoattractnat Protein-1 studies. Optimize your research with PubCompare.ai!
Monocyte Chemoattractant Protien-1 (MCP-1) plays a central role in the recruitment and activation of monocytes and macrophages to sites of inflammation, making it a key mediator in a variety of inflammatory and immune-related disease processes. MCP-1 has been implicated in the pathogenesis of conditions such as atherosclerosis, rheumatoid arthritis, diabetic nephropathy, multiple sclerosis, and Alzheimer's disease, among others. By promoting the infiltration and activation of monocytes/macrophages, MCP-1 contributes to tissue damage, chronic inflammation, and disease progression in these disorders. Accurate measurement and analysis of MCP-1 levels is crucial for understanding its role in health and disease, and optimizing your research in this area can be greatly facilitated by the use of PubCompare.ai's AI-driven platform.
More about "Monocyte Chemoattractant Protein-1"
Monocyte Chemoattractant Protein-1 (MCP-1), also known as CCL2, is a small cytokine that plays a crucial role in the recruitment and activation of monocytes and macrophages to sites of inflammation.
This chemokine is involved in a variety of inflammatory and immune responses and has been implicated in the pathogenesis of numerous disease states.
MCP-1 is produced by a wide range of cell types, including endothelial cells, smooth muscle cells, and various immune cells.
It exerts its effects by binding to the CCR2 receptor, which triggers intracellular signaling cascades that promote monocyte migration and activation.
Accurate measurement and analysis of MCP-1 levels is crucial for understanding its role in health and disease.
The Bio-Plex 200 system, a multiplex assay platform, can be used to measure MCP-1 levels along with other cytokines and chemokines.
The TRIzol reagent is commonly used for RNA extraction, and the RNeasy Mini Kit can be utilized for purification.
Flow cytometry, using a FACSCanto II flow cytometer, can also be employed to analyze MCP-1 expression and related immune cell populations.
To optimize your Monocyte Chemoattractant Protein-1 research, the PubCompare.ai AI-driven platform can be an invaluable resource.
This tool helps researchers locate the best protocols from literature, pre-prints, and patents, allowing for the identification of the most effective methods and products.
Additionally, the Milliplex Map Kit and CBA Mouse Inflammation Kit provide comprehensive solutions for the measurement of MCP-1 and other inflammatory markers.
By leveraging these tools and resources, you can streamline your Monocyte Chemoattractant Protein-1 studies, enhance reproducibility, and gain deeper insights into the role of this important cytokine in health and disease.
Don't miss out on the opportnuity to maximize your research potential with PubCompare.ai and the related technologies.